News & Analysis as of

Pharmaceutical Industry › Subpoenas › Department of Justice (DOJ)

Womble Bond Dickinson

[Webinar] Second Annual Health Care Fraud Symposium - December 10th, 12:30 pm - 2:30 pm ET

Womble Bond Dickinson on

Heath care fraud remains a top priority for the DOJ. This year’s National Health Care Fraud Takedown was the biggest in United States history, resulting in the prosecution of 324 defendants in connection with over $14.6...more

Womble Bond Dickinson

[Webinar] First Annual Health Care Fraud Symposium - March 14th, 12:00 pm - 1:30 pm ET

Womble Bond Dickinson on

Health Care fraud is a growing national issue. The National Heath Care Anti-Fraud Association estimates that health care fraud costs the nation about $68 billion annually — about 3 percent of the nation's $2.26 trillion in...more

Skadden, Arps, Slate, Meagher & Flom LLP

Cross-Border Investigations Update - September 2019

Skadden, Arps, Slate, Meagher & Flom LLP on

This issue of Skadden’s semiannual Cross-Border Investigations Update takes a close look at recent cases, regulatory activity and other key developments, including a review of the first year of GDPR enforcement, analysis of...more

Foley & Lardner LLP

Scientific Research Misconduct vs. Fraud: How to Tell the Difference

Foley & Lardner LLP on

For years, misconduct in scientific research was policed primarily by the Office of Research Integrity (ORI) at the U.S. Department of Health and Human Services. After a lengthy and confidential review, an institution...more

Morgan Lewis

2016 Mid-Year Global Cartel Enforcement Report

Morgan Lewis on

Cartel enforcement activity promises to remain busy In the coming months and into 2017 Cartel enforcement remains a priority for competition authorities around the world. Global cartel fines totaled more than $6...more

Patterson Belknap Webb & Tyler LLP

The Government’s Generic Price-Fixing Investigation Targets Allergan’s Actavis Unit

Patterson Belknap Webb & Tyler LLP on

This is our fourth post on the DOJ’s expanding investigation into possible price fixing by generic drug manufacturers. (Click here, here, and here to read our prior posts.) Since our last update, the DOJ has subpoenaed...more

Wilson Sonsini Goodrich & Rosati

Update on the DOJ's Criminal Investigation into Generic Pharmaceuticals

Wilson Sonsini Goodrich & Rosati on

The Department of Justice Antitrust Division's (DOJ's) investigation into the generic pharmaceutical industry may be expanding. On March 15, 2015, a third generic manufacturer disclosed that it received a subpoena from the...more

Patterson Belknap Webb & Tyler LLP

Public Outcry Over Generic Price Hikes Spurs Criminal Investigations

Patterson Belknap Webb & Tyler LLP on

Drug manufacturers Impax Laboratories and Lannett Company have come under public scrutiny and, more recently, criminal investigation for their recent generic drug price increases. The companies disclosed in recent SEC filings...more

Wilson Sonsini Goodrich & Rosati

DOJ Investigation into Generic Pharmaceutical Pricing Signals Potential Criminal Exposure

Wilson Sonsini Goodrich & Rosati on

The United States Department of Justice Antitrust Division (DOJ) recently served two U.S.-based generic pharmaceutical manufacturers with criminal grand jury subpoenas. It is reported that the subpoenas request all...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide